AlzeCure Pharma AB (publ)

SSE:ALZCUR.ST

2.49 (SEK) • At close February 20, 2024
Bedrijfsnaam AlzeCure Pharma AB (publ)
Symbool ALZCUR.ST
Munteenheid SEK
Prijs 2.49
Beurswaarde 154,596,630
Dividendpercentage 0%
52-weken bereik 2.03 - 6.54
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Martin Jönsson
Website https://www.alzecurepharma.se

An error occurred while fetching data.

Over AlzeCure Pharma AB (publ)

AlzeCure Pharma AB (publ), a pharmaceutical company, develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is developing drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its pipeline drug candidates include ACD856, which is in phase I

Vergelijkbare Aandelen

Sprint Bioscience AB (publ) logo

Sprint Bioscience AB (publ)

SPRINT.ST

0.876 SEK

Saniona AB (publ) logo

Saniona AB (publ)

SANION.ST

2.105 SEK

AroCell AB (publ) logo

AroCell AB (publ)

AROC.ST

0.405 SEK

Financiële Gegevens

Cijfers zijn in miljoenen (SEK)

Cijfers zijn in miljoenen (SEK)